Your browser doesn't support javascript.
loading
Survival outcomes in patients with BRCA mutated, variant of unknown significance, and wild type ovarian cancer treated with PARP inhibitors.
Musacchio, Lucia; Boccia, Serena; Marchetti, Claudia; Minucci, Angelo; Camarda, Floriana; Cassani, Chiara; Ventriglia, Jole; Salutari, Vanda; Ghizzoni, Viola; Giudice, Elena; Perri, Maria Teresa; Carbone, Maria Vittoria; Ricci, Caterina; Pignata, Sandro; Fagotti, Anna; Scambia, Giovanni; Lorusso, Domenica.
Afiliação
  • Musacchio L; Department of Women and Child Health, Division of Gynecologic Oncology, Fondazione Policlinico Universitario A.Gemelli IRCCS, Rome, Italy.
  • Boccia S; Department of Women and Child Health, Division of Gynecologic Oncology, Fondazione Policlinico Universitario A.Gemelli IRCCS, Rome, Italy.
  • Marchetti C; Department of Women and Child Health, Division of Gynecologic Oncology, Fondazione Policlinico Universitario A.Gemelli IRCCS, Rome, Italy.
  • Minucci A; Departmental Unit of Molecular and Genomic Diagnostic, Fondazione Policlinico Universitario A.Gemelli IRCCS, Rome, Italy.
  • Camarda F; Department of Women and Child Health, Division of Gynecologic Oncology, Fondazione Policlinico Universitario A.Gemelli IRCCS, Rome, Italy.
  • Cassani C; Fondazione IRCCS Policlinico San Matteo, Pavia, Lombardia, Italy.
  • Ventriglia J; Department of Urology and Gynecology, Istituto Nazionale Tumori IRCCS Fondazione G.Pascale, Naples, Italy.
  • Salutari V; Department of Women and Child Health, Division of Gynecologic Oncology, Fondazione Policlinico Universitario A.Gemelli IRCCS, Rome, Italy.
  • Ghizzoni V; Department of Women and Child Health, Division of Gynecologic Oncology, Fondazione Policlinico Universitario A.Gemelli IRCCS, Rome, Italy.
  • Giudice E; Department of Women and Child Health, Division of Gynecologic Oncology, Fondazione Policlinico Universitario A.Gemelli IRCCS, Rome, Italy.
  • Perri MT; Department of Women and Child Health, Division of Gynecologic Oncology, Fondazione Policlinico Universitario A.Gemelli IRCCS, Rome, Italy.
  • Carbone MV; Department of Women and Child Health, Division of Gynecologic Oncology, Fondazione Policlinico Universitario A.Gemelli IRCCS, Rome, Italy.
  • Ricci C; Department of Women and Child Health, Division of Gynecologic Oncology, Fondazione Policlinico Universitario A.Gemelli IRCCS, Rome, Italy.
  • Pignata S; Department of Urology and Gynecology, Istituto Nazionale Tumori IRCCS Fondazione G.Pascale, Naples, Italy.
  • Fagotti A; Department of Women and Child Health, Division of Gynecologic Oncology, Fondazione Policlinico Universitario A.Gemelli IRCCS, Rome, Italy.
  • Scambia G; Department of Life Science and Public Health, Catholic University of Sacred Heart Agostino Gemelli, Rome, Italy.
  • Lorusso D; Department of Women and Child Health, Division of Gynecologic Oncology, Fondazione Policlinico Universitario A.Gemelli IRCCS, Rome, Italy.
Int J Gynecol Cancer ; 33(6): 922-928, 2023 06 05.
Article em En | MEDLINE | ID: mdl-36759000
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias Ovarianas / Inibidores de Poli(ADP-Ribose) Polimerases Limite: Female / Humans Idioma: En Ano de publicação: 2023 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias Ovarianas / Inibidores de Poli(ADP-Ribose) Polimerases Limite: Female / Humans Idioma: En Ano de publicação: 2023 Tipo de documento: Article